课题基金 / 基金详情

TREATMENT OF HYPERACTIVE CHILDREN WITH MONOAMINE OXIDASE INHIBITORS

TREATMENT OF HYPERACTIVE CHILDREN WITH MONOAMINE OXIDASE INHIBITORS
用单胺氧化酶抑制剂治疗多动儿童
批准号:
4696312
负责人:
J L RAPOPORT
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至

项目摘要

项目成果

J L RAPOPORT的其他基金

相似基金

相关文献

中文摘要
翻译
30名患有儿童注意力缺陷障碍(ADD)的儿童被 用选择性或非选择性MAO抑制剂处理。主要发现 到目前为止,选择性MAO-A抑制剂Clorgyline和 三羟环丙胺是一种非选择性的抑制剂,可以有效地降低 多动症和提高注意力。有一个显著的下降, 尿MHPG排泄量与行为的相关性 对MAOIs和d-苯丙胺的改善。然而,这一下降在 MHPG在停药后持续了几个星期 安非他明和安非他明的药物立即行为反弹 毛油。 这项研究支持儿茶酚胺代谢的改变是介导 兴奋剂药物的作用。1-乙丙烯基的对照试验 选择性MAO-B抑制剂,正在进行中。
英文摘要
Thirty children with childhood Attention Deficit Disorder (ADD) have been treated with a selective or nonselective MAO inhibitor. The major findings to date are that both clorgyline, a selective MAO-A inhibitor, and tranylcypromine, a nonselective inhibitor, were effective in decreasing hyperactivity and improving attention. There was a significant decrease in urinary MHPG excretion which showed some correlation with behavioral improvement both on MAOIs and on d-amphetamine. However, this decrease in MHPG persisted for several weeks after drugs were stopped while there was immediate behavioral rebound off drug for both amphetamine and for the MAOIs. The study supports alteration of catecholamine metabolism as mediating the effects of stimulant medication. A controlled trial of 1-deprenyl, a selective MAO-B inhibitor, is ongoing.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DIAGNOSIS IN CHILD PSYCHIATRY
EVALUATION AND TREATMENT OF OBSESSIVE COMPULSIVE DISORDER AND RELATED DISORDERS
CHILDHOOD ONSET SCHIZOPHRENIA
BRAIN STRUCTURE AND FUNCTION IN DEVELOPMENTAL NEUROPSYCHOLOGICAL DISORDERS
海外基金